Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 37, 2023 - Issue 17
236
Views
1
CrossRef citations to date
0
Altmetric
Short communications

Chemical components and monoamine oxidase B inhibition activities from the tubers of Sauromatum giganteum (Engl.) Cusimano & Hett

, , , &
Pages 2916-2923 | Received 04 Apr 2022, Accepted 07 Oct 2022, Published online: 27 Oct 2022

References

  • Ai FW, Zhang S, Li YF. 2010. Chemical constituents in the root of Typhonium giganteum. Zhongcaoyao 41: 201–203.
  • Al-Madhagy SA, Gad SS, Mostafa ES, Angeloni S, Saad MA, Sabry OM, Caprioli G, El-Hawary SS. 2022. A new arsenal of polyphenols to make Parkinson’s disease extinct: HPLC-MS/MS profiling, very interesting MAO-B inhibitory activity and antioxidant activity of Otostegia fruticosa. Nat Prod Res. DOI: 10.1080/14786419.2022.2044811
  • Bai S, Song Y, Huang X, Peng L, Jia J, Liu Y, Lu H. 2016. Statin use and the risk of Parkinson’s disease: An updated meta-analysis. PLoS One. 11(3):e0152564–12.
  • Castillo J, Hung J, Rodriguez M, Bastidas E, Laboren I, Jaimes A. 2005. LED fluorescence spectroscopy for direct determination of monoamine oxidase B inactivation. Anal Biochem. 343(2):293–298.
  • Chang SW, Kim KH, Lee K, Choi SU, Ryu SY, Lee K. 2009. Phytochemical constituents of Bistorta manshuriensis. Nat Prod Sci. 15:234–240.
  • Chang HS, Peng CJ, Cheng MJ, Wu HC, Chan HY, Hsieh SY, Yuan GF, Chen IS. 2018. Chemical constituents of the endophytic fungus Phomopsis asparagi isolated from the plant Peperomia sui. Chem. Chem Nat Compd. 54(3):504–508.
  • Chen XS, Chen DH, Si JY, Tu GZ. 2001. Chemical constituents of Typhonium giganteum Engl. J Asian Nat Prod Res. 3(4):277–283.
  • Chen X, Wu YL, Chen D. 2002. Structure determination and synthesis of a new cerebroside isolated from the traditional Chinese medicine Typhonium giganteum Engl. Tetrahedron Lett. 43(19):3529–3532.
  • Chi S, Cai W, Liu P, Zhang Z, Chen X, Gao L, Qi J, Bi L, Chen L, Qi Z. 2010. Baifuzi’ reduces transient ischemic brain damage through an interaction with the STREX domain of BK-Ca channels. Cell Death Dis. 1(1):e13–e13.
  • Di-Pietro ME, Mannu A, Mele A. 2020. NMR determination of free fatty acids in vegetable oils. Proc. 8(4):410.
  • Drui G, Carnicella S, Carcenac C, Favier M, Bertrand A, Boulet S, Savasta M. 2014. Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease. Mol Psychiatry. 19:358–367.
  • Edmondson DE, Binda C. 2018. Monoamine oxidases. Subcell Biochem. 87:117–139.
  • Fang Z, Tang Y, Ying J, Tang C, Wang Q. 2020. Traditional Chinese medicine for anti-Alzheimer’s disease: berberine and evodiamine from Evodia rutaecarpa. Chin Med. 15:82.
  • Gao SH, Gong YF, Sun QJ, Bai J, Wang L, Fan ZQ, Sun Y, Su YJ, Gang J, Ji YB. 2015. Screening antitumor bioactive fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and sensitive cell lines with the serum pharmacology method and identification by UPLC-TOF-MS. Molecules. 20:4290–4306.
  • Gao SB, Wang CM, Chen XS, Yu WW, Mo BW, Li CH. 2007. Cerebrosides of Baifuzi, a novel potential blocker of calcium-activated chloride channels in rat pulmonary artery smooth muscle cells. Cell Biol Int. 31(9):908–915.
  • Grosch J, Winkler J, Kohl Z. 2016. Early degeneration of both dopaminergic and serotonergic axons-A common mechanism in Parkinson’s disease. Front Cell Neurosci. 10:293.
  • He DH, Chen JX, Fu X, Guo D, Le Xia B, Liu GH, Ding KY, Fang DM, Zhou Y. 2020. A 6/5/5/7 heterotetracyclic indole derivative alkaloid isolated from Typhonium giganteum. Tetrahedron Lett. 61(7):151497.
  • Hong L, Guo Z, Huang K, Wei S, Liu B, Meng S, Long C. 2015. Ethnobotanical study on medicinal plants used by Maonan people in China. J Ethnobiol Ethnomed. 11:32.
  • Ishikawa K, Takeda H, Wakana D, Sato F, Hosoe T. 2016. Isolation and identification of berberine and berberrubine metabolites by berberine-utilising bacterium Rhodococcus sp. strain BD7100. Biosci Biotechnol Biochem. 80:856–862.
  • Jiang T, Zhang J, Zhang Y, Shi Y, Wang J, Ma R. 2015. Volatile constituents in Du Jiao Lian and their effects on proliferation of breast cancer T47D cell lines. Biomed Res. 26:431–436.
  • Jin Y, Fan JT, Gu XL, Zhang LY, Han J, Du SH, Zhang AX. 2017. Neuroprotective activity of cerebrosides from Typhonium giganteum by Regulating Caspase-3 and Bax/Bcl-2 Signalling Pathways in PC12 Cells. J Nat Prod. 80(6):1734–1741.
  • Jo SK, Kim IS, Yoon KS, Yoon HH, Yoo HH. 2015. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson’s disease. Z Naturforsch A. 240:273–281.
  • Jung HA, Min BS, Yokozawa T, Lee JH, Kim YS, Choi JS. 2009. Anti-Alzheimer and antioxidant activities of Coptidis rhizoma alkaloids. Biol Pharm Bull. 32:1433–1438.
  • Khalivulla SI, Mohammed A, Sirajudeen KNS, Shaik MI, Ye W, Korivi M. 2019. Novel phytochemical constituents and anti-cancer activities of the Genus, Typhonium. Curr Drug Metabol. 20(12):946–957.
  • Kouli A, Torsney KM, Kuan WL. 2018. Parkinson’s disease: etiology, neuropathology, and pathogenesis. In: Stoker TB, editors. Parkinson’s disease: pathogenesis and clinical aspects. Codon Publications. Chapter 1, Brisbane, Australia. ISBN: 978-0-9944381-6-4
  • Liang JB, Yang ZD, Shu ZM, Yu CC. 2014. A rapid thin-layer chromatography bioautographic method for detecting the monoamine oxidase inhibitors in plants. Nat Prod Res. 28(17):1318–1321.
  • Li Q, Jiang C, Zu Y, Song Z, Zhang B, Meng X, Qiu W, Zhang L. 2011. SFE-CO2 extract from Typhonium giganteum Engl. tubers induce apoptosis in human hepatoma SMMC-7721 cells involvement of a ROS-mediated mitochondrial pathway. Molecules. 16:8228–8243.
  • Li G, Ma J, Cui S, He Y, Xiao Q, Liu J, Chen S. 2019. Parkinson’s disease in China: A forty-year growing track of bedside work. Transl Neurodegener. 8:1–9.
  • Liu KW, Li ZL, Pu SB, Xu DR, Zhou HH, Shen WB. 2014. Chemical constituents of the rhizome of T. giganteum. Chem Nat Comp. 50:1079–1081.
  • López-Salazar H, Camacho-Díaz BH, Ávila-Reyes SV, Pérez-García MD, González-Cortazar M, Arenas-Ocampo ML, Jiménez-Aparicio AR. 2019. Identification and quantification of β-Sitosterol-β-D-glucoside of an ethanolic extract obtained by microwave-assisted extraction from Agave angustifolia Haw. Molecules. 24(21):3926.
  • Magalingam KB, Radhakrishnan A, Haleagrahara N. 2016. Protective effects of quercetin glycosides, rutin, and isoquercetrin against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in rat pheochromocytoma (PC-12) cells. Int J Immunopathol Pharmacol. 29(1):30–39.
  • Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. 2019. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 30(16):2785–2791.
  • National Pharmacopoeia Committee. 2015. Pharmacopoeia of the People’s Republic of China. Beijing: China Medical Science Press; p. 106.
  • Pateh UU, Haruna AK, Garba M, Iliya I, Sule IM, Abubakar MS, Ambi AA. 2009. Isolation of stigmasterol, β-sitosterol and 2-hydroxyhexadecanoic acid methyl ester from the rhizomes of Stylochiton lancifolius Pyer and Kotchy (Araceae). Niger J Pharm Sci. 8:19–25.
  • Peixoto MA, Kato L, Alves de Oliveira CM, Gontijo B, da Silva CC, Pomini AM, Klein-junior LC, Passos CDS, Henriques AT, Bannwart G, et al. 2021. Kopsanone and N-oxide isolated from Aspidosperma macrocarpon Mart. (Apocynaceae) leaves and their MAO-A inhibitory activity. Nat Prod Res. 35(23):5465–5469.
  • Ramadan S, Sabry MM, Saad MA, Angeloni S, Sabry OM, Caprioli G, El Zalabani SM. 2021. Dismantling Parkinson’s disease with herbs: MAO-B inhibitory activity and quantification of chemical constituents using HPLC-MS/MS of Egyptian local market plants. Nat Prod Res. DOI: 10.1080/14786419.2021.2013836
  • Robakis D, Fahn S. 2015. Defining the role of the monoamine oxidase-B inhibitors for Parkinson’s Disease. CNS Drugs. 29:433–441.
  • Shabalin K, Nerinovski K, Yakimov A, Kulikova V, Svetlova M, Solovjeva L, Khodorkovskiy M, Gambaryan S, Cunningham R, Migaud M, et al. 2018. NAD metabolome analysis in human cells using 1H-NMR spectroscopy. Int J Mol Sci. 19(12):3906.
  • Shu P, Zhang L, Liu W, Fei Y, Sun M, Lou Y, Liu A, Yu M, Li J, Wei X, et al. 2020. Chemical constituents from Typhonium giganteum rhizome and their antioxidant, tyrosinase inhibitory activities Rec. Nat Prod. 15:53–58.
  • Song Y, Bao W, Li B, Yang G, Pang Z. 2013. Study on antioxidant activity of Typhonium giganteum Engl. tuber extracts in vitro and in vivo. J Biomim Biomater Tissue Eng. 112:2.
  • Song Y, Meng BLY. 2012. Advances in studies on chemical constituents and biological activities of T. giganteum Engl. tuber extracts. In: 2012 International Conference on Biomedical Engineering and Biotechnology; p. 30–33.
  • Suttiarporn P, Chumpolsri W, Mahatheeranont S, Luangkamin S, Teepsawang S, Leardkamolkarn V. 2015. Structures of phytosterols and triterpenoids with potential anti-cancer activity in the bran of black non-glutinous rice. Nutrients. 7:167–1687.
  • Szwajgier D, Borowiec K, Zapp J. 2020. Activity-guided isolation of cholinesterase inhibitors quercetin, rutin and kaempferol from Prunus persica fruit. Z Naturforsch C. 75:87–96.
  • Utari F, Itam A, Syafrizayanti S, Putri WH, Ninomiya M, Koketsu M, Tanaka KEM. 2019. Isolation of flavonol rhamnosides from Pometia pinnata leaves and investigation of α-glucosidase inhibitory activity of flavonol derivatives. J Appl Pharm Sci. 9:53–65.
  • Wang W, Wu H, Yu H, Zhang X, Cui G, Wang K, Mao S, Pan Y. 2017. Typhonium giganteum lectin exerts A pro-inflammatory effect on RAW 264.7 via ROS and the NF-kB signalling pathway. Toxins. 9(9):275.
  • Xu HN, Qi JH, Wang GF, Deng H, Qi Z. 2011. The effect of single cerebroside compounds on activation of BKCa channels. J Mol Membr Biol. 28:145–154.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.